Masimo Corp(MASI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 123.41 | EPS (ttm) | 1.46 | Insider Own | 2.94% | Shs Outstand | 52.4M | Perf Week | - |
| Market Cap | 9.42B | Forward P/E | 26.9 | EPS next Y | 10.76% | Insider Trans | -1.2% | Shs Float | 50.8M | Perf Month | 0.64% |
| Enterprise Value | 9.79B | PEG | - | EPS next Q | - | Inst Own | 94.61% | Short Float | 6.89% | Perf Quarter | 2.2% |
| Income | 0.08B | P/S | 6.05 | EPS this Y | 57.7% | Inst Trans | - | Short Ratio | 3.08 | Perf Half Y | 30.97% |
| Sales | 1.56B | P/B | 11.95 | EPS next 5Y | - | ROA | 11.02% | Short Interest | 3.50M | Perf YTD | 38.36% |
| Book/sh | 15.06 | P/C | 75.63 | EPS past 3/5Y | - | ROE | 24.99% | 52W High | -0.02% ($179.99) | Perf Year | 4.7% |
| Cash/sh | 2.38 | P/FCF | 44.68 | Sales past 3/5Y | -9.14% 5.95% | ROIC | 5.99% | 52W Low | 42.89% ($125.94) | Perf 3Y | 15.1% |
| Dividend Est. | - | EV/EBITDA | 28.14 | EPS Y/Y TTM | 116.03% | Gross Margin | 61.73% | Volatility(W/M) | 0.09% 0.16% | Perf 5Y | -15.37% |
| Dividend TTM | - | EV/Sales | 6.28 | Sales Y/Y TTM | -21.03% | Oper. Margin | 19.86% | ATR (14) | 0.39 | Perf 10Y | 243.29% |
| Dividend Ex-Date | 2012/11/23 | Quick Ratio | 1.45 | EPS Q/Q | 133.86% | Profit Margin | 4.84% | RSI (14) | 74.83 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.68 | Sales Q/Q | 8.49% | SMA20 | 0.65% ($178.79) | Beta | 1.09 | Target Price | $180 |
| Payout | - | Debt/Eq | 0.62 | Earnings | 2026/05/12 | SMA50 | 0.78% ($178.56) | Rel Volume | 0 | Prev Close | $179.95 |
| Employees | 7500 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | -112.17% 1.1% | SMA200 | 15.43% ($155.9) | Avg Volume(3M) | 1.14M | Price | $179.95 |
| IPO | 2007/8/8 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
A U.S. medical device company that supplies patient monitoring equipment and sensors to hospitals, including devices that measure blood oxygen saturation. Its strengths lie in its recurring revenue from disposable sensors used for each patient and its measurement technology.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
MASI makes money exceptionally well
Of every $100 in sales, $19.86 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +57.7% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $2,814. Peers typically go for $1,688.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -15.4%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 94.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 143 in the industry
Based on market cap of $9B.
PODD#15 Insulet Corp $10B PER 29.7 
BIO#16 Bio-Rad Laboratories Inc $10B PER 45.1 MASI#17 Masimo Corp $9B PER 123.4 
TXG#17 10x Genomics Inc $9B PER - 
BRKR#18 Bruker Corp $9B PER - 
FAQ
What kind of company is MASI?
MASI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MASI?
The market cap of MASI is approximately $9.4B, ranking 975 within its sector.
What is the P/E ratio of MASI?
MASI has a P/E ratio of approximately 123.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MASI?
MASI has recorded a 52-week high of $179.99 and a low of $125.94.
